Natus Medical, Inc. (BABY) Reports In-Line Q3 EPS; Guides Q4, FY11 EPS ,Revs
Get Alerts BABY Hot Sheet
Join SI Premium – FREE
Natus Medical, Inc. (NASDAQ: BABY) reported Q3 EPS of $0.07, in-line with the analyst estimate of $0.07. Revenue for the quarter came in at $51.3 million versus the consensus estimate of $51.49 million.
Natus Medical, Inc. sees FY2011 EPS of $0.48, versus the consensus of $0.47. Natus Medical, Inc. sees FY2011 revenue of $234 million, versus the consensus of $233.41 million.
Natus Medical, Inc. sees Q4 2011 EPS of $0.15, versus the consensus of $0.15. Natus Medical, Inc. sees Q4 2011 revenue of $65 million, versus the consensus of $64.56 million.
Natus Medical, Inc. sees FY2011 EPS of $0.48, versus the consensus of $0.47. Natus Medical, Inc. sees FY2011 revenue of $234 million, versus the consensus of $233.41 million.
Natus Medical, Inc. sees Q4 2011 EPS of $0.15, versus the consensus of $0.15. Natus Medical, Inc. sees Q4 2011 revenue of $65 million, versus the consensus of $64.56 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Verra Mobility (VRRM) Tops Q3 EPS by 10c ; Offers Guidance
- Canadian National Railway (CNI) Tops Q3 EPS by 8c
- Dominion Energy (D) Tops Q3 EPS by 9c, Beats on Revenue; Offers FY26 EPS Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share